Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 20.07.2026 1 Am J Physiol Lung Cell Mol Physiol 1 Ann Am Thorac Soc 1 bioRxiv 1 Blood Adv 2 BMC Cardiovasc Disord 1 Can J Cardiol 1 Circulation 1 Curr Opin Immunol 1 Echocardiography 1 Eur J Obstet Gynecol Reprod Biol 1 Front Immunol 1 Front Pharmacol 1 Hepatology 1 Int J Mol Sci 2 J Am Heart Assoc 1 J Heart Lung Transplant 1 J Infect Public Health 1 J Inflamm (Lond) 1 J Nanobiotechnology 3 J Thorac Dis 1 JACC Case Rep 1 Kidney Dis (Basel) 1 Pharmacoeconomics 3 Pulm Circ 1 Respir Investig 1 Respir Res 1 Rheumatol Int 1 Zhongguo Dang Dai Er Ke Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Physiol Lung Cell Mol Physiol

1. ZAZZERON L, Tattersfield H, Moore E, Xiao X, et al
   Lifelong Hypoxia Produces Multigenerational Developmental Lung Disease and Pulmonary Hypertension in Mice.
   Am J Physiol Lung Cell Mol Physiol. 2026 Jul 11. doi: 10.1152/ajplung.00199.2026
   PubMed         Abstract available
   
   

   
   Ann Am Thorac Soc

2. SANDERS R, Walsh T, Baird GL, Atalay MK, et al
   Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY): A Randomized, Double-Blind, Placebo-Controlled Crossover Trial.
   Ann Am Thorac Soc. 2026 Jul 14:aaoag195. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   bioRxiv

3. LIN CY, Gaweda B, Manthatis N, Sreedhar S, et al
   The Tricuspid Valve Maladapts in a Pulmonary Hypertension Rat Model.
   bioRxiv [Preprint]. 2026 Jul 12:2026.07.08.737279.
   PubMed         Abstract available
   
   

   
   Blood Adv

4. OLANIRAN KO, Nero AC, Toto RD
   Estimated glomerular filtration rate discordance and cardiopulmonary morbidity in sickle cell disease.
   Blood Adv. 2026;10:5033-5044.
   PubMed         Abstract available
   
   

   
   BMC Cardiovasc Disord

5. SU X, Yu C, Liu J
   Reversible severe pulmonary hypertension triggered by atrioventricular dyssynchrony in complete heart block: a case report.
   BMC Cardiovasc Disord. 2026 Jul 17. doi: 10.1186/s12872-026-05999.
   PubMed         Abstract available
   
   
6. ZHAO S, Lu ZY, Zhou P, Xiong L, et al
   Early postoperative treprostinil in for severe pulmonary arterial hypertension in a high-risk pediatric patient with complete atrioventricular septal defect: a case report.
   BMC Cardiovasc Disord. 2026;26:600.
   PubMed         Abstract available
   
   

   
   Can J Cardiol

7. ANDROSHCHUK V, Long E, Chehab O, Wilcox J, et al
   Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation: The Prognostic Effect of Right-sided cardiopulmonary Remodelling.
   Can J Cardiol. 2026;42:1458-1468.
   PubMed         Abstract available
   
   

   
   Circulation

8. HUMBERT M, Zeder K, Kovacs G, Weatherald J, et al
   Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.
   Circulation. 2026;154:156-177.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

9. DHANANI Z, Vorselaars AD, Gupta R, Spagnolo P, et al
   When the lung is at risk: diagnosis, manifestations, and complications of pulmonary sarcoidosis.
   Curr Opin Immunol. 2026;101:102792.
   PubMed         Abstract available
   
   

   
   Echocardiography

10. FUCHIGAMI Y
    Machine-Reported Electrocardiographic Right Axis Deviation or Right Ventricular Hypertrophy and Echocardiographic Pulmonary Hypertension Phenotypes and Right-Heart Abnormalities.
    Echocardiography. 2026;43:e70539.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

11. MU L, Yuan H, Zhang J, Wu J, et al
    SPP1 improves early risk assessment of postpartum adverse events in pulmonary arterial hypertension complicated with pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2026;324:115254.
    PubMed         Abstract available
    
    

    
    Front Immunol

12. ZHAO Y, An Y, Yang Q, Ma Z, et al
    Immunological coagulation dual axis stratification identifies ultra high-risk phenotypes in systemic sclerosis.
    Front Immunol. 2026;17:1866374.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

13. YAO M, Chen R, Shen M, Xu Z, et al
    TRAF6 promotes pulmonary hypertension by enhancing K63-linked ubiquitination and activation of STAT3.
    Front Pharmacol. 2026;17:1850163.
    PubMed         Abstract available
    
    

    
    Hepatology

14. KROWKA MJ, DuBrock HM, Raevens S, Fallon MB, et al
    Unmet needs in diagnosis and management of portopulmonary hypertension: How far have we reached?
    Hepatology. 2026;84:573-581.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

15. HU J, Qiao Y, Lei G, Gai X, et al
    Serum Pharmacochemistry-Guided DARTS-MS Profiling Reveals Potential Mechanisms of Caragana jubata Against Hypoxic Pulmonary Hypertension.
    Int J Mol Sci. 2026;27:5815.
    PubMed         Abstract available
    
    

    
    J Am Heart Assoc

16. FARHA S, Hu B, Chen R, Barnard J, et al
    Endotypes of Vascular Health Predict Transplantation-Free Survival in Pulmonary Hypertension.
    J Am Heart Assoc. 2026 Jul 17:e048795. doi: 10.1161/JAHA.125.048795.
    PubMed         Abstract available
    
    
17. BOGER R
    Reclustering of Pulmonary Hypertension Patients Along Molecular Pathophysiology Traits Better Predicts Long-Term Outcome Than Currently Used Classification.
    J Am Heart Assoc. 2026 Jul 17:e052334. doi: 10.1161/JAHA.126.052334.
    PubMed        
    
    

    
    J Heart Lung Transplant

18. COOPER D, Turner D, Cooper DS, Hayes D Jr, et al
    Rethinking paracorporeal lung assist device support in the modern era: Why so different than ECMO?
    J Heart Lung Transplant. 2026;45:1238-1240.
    PubMed         Abstract available
    
    

    
    J Infect Public Health

19. ALGHOUNAIM M, Shaheen NA, Aldaithan A, Awlad Thani S, et al
    Clinical phenotypes and mortality predictors in pediatric critical pertussis: A multinational study.
    J Infect Public Health. 2026;19:103276.
    PubMed         Abstract available
    
    

    
    J Inflamm (Lond)

20. WANG XB, Gao ZQ, Yu Y, Lu YF, et al
    Differences in systemic inflammation and prethrombotic biomarkers between AECOPD patients with and without pulmonary hypertension.
    J Inflamm (Lond). 2026 Jul 15. doi: 10.1186/s12950-026-00508.
    PubMed         Abstract available
    
    

    
    J Nanobiotechnology

21. WU H, Zhou R, Hui W, Qiao S, et al
    Hypoxia-injured pulmonary vascular targeting and microenvironment-responsive nanoparticle to treat hypoxic pulmonary hypertension.
    J Nanobiotechnology. 2026 Jul 13. doi: 10.1186/s12951-026-04680.
    PubMed         Abstract available
    
    

    
    J Thorac Dis

22. GESANG Q, Danzeng Z, Suona Y, Luo Q, et al
    Epidemiological patterns of pulmonary hypertension at 3,658 meters: insights from a Tibet plateau retrospective study.
    J Thorac Dis. 2026;18:633.
    PubMed         Abstract available
    
    
23. LI F, Ma X, Li R, Li B, et al
    Identification of neutrophil extracellular traps-related genes as feature genes and potential therapeutic targets in pulmonary hypertension.
    J Thorac Dis. 2026;18:627.
    PubMed         Abstract available
    
    
24. BACHAR R, Tager D, Berro J, Nero N, et al
    Pulmonary hypertension following lung transplant: a systematic review.
    J Thorac Dis. 2026;18:685.
    PubMed         Abstract available
    
    

    
    JACC Case Rep

25. BHARDWAJ A, Valadi Ramakrishnan S, Joseph D, Nathan S, et al
    High-Output Heart Failure and Pulmonary Hypertension Caused by Arteriovenous Graft: Diagnosis and Treatment.
    JACC Case Rep. 2026 Jul 15:109095. doi: 10.1016/j.jaccas.2026.109095.
    PubMed         Abstract available
    
    

    
    Kidney Dis (Basel)

26. SONG J, Bian X, Zhuang B, Liu X, et al
    Risk Factors for Pulmonary Hypertension and Survival in Hemodialysis Patients: Are We Overlooking Serum Magnesium?
    Kidney Dis (Basel). 2026;12:554-563.
    PubMed         Abstract available
    
    

    
    Pharmacoeconomics

27. ALSUMALI A, Pontinha VM, Cohen BG, Levy M, et al
    Application of a Prevalence-Adjusted Cost-Effectiveness Threshold Framework for Pulmonary Arterial Hypertension.
    Pharmacoeconomics. 2026;44:975-983.
    PubMed         Abstract available
    
    

    
    Pulm Circ

28. AVITABILE CM, Butler K, Mondal A, Frank DB, et al
    Right Ventricular Function Improves With Pulmonary Vasodilator Treatment in Pediatric Patients With Pulmonary Hypertension and Multivessel Pulmonary Vein Stenosis in a Single Center Cohort.
    Pulm Circ. 2026;16:e70346.
    PubMed         Abstract available
    
    
29. ZHYVYLO I, Sood N, Pugashetti JV, Linderholm AL, et al
    Smoking-Related Clinical and Molecular Abnormalities in Idiopathic Pulmonary Fibrosis-Associated Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70349.
    PubMed         Abstract available
    
    
30. BATTILANA B, Stoeck CT, Robert F, Senbaklavaci O, et al
    Minimally Invasive Porcine Model for Chronic Thromboembolic Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70344.
    PubMed         Abstract available
    
    

    
    Respir Investig

31. IDEI S, Tanaka Y, Dong F, Okamura K, et al
    Pulmonary vascular resistance is associated with two-year clinical outcomes in non-hypoxemic COPD with mild pulmonary hemodynamic abnormalities.
    Respir Investig. 2026;64:101450.
    PubMed         Abstract available
    
    

    
    Respir Res

32. DAI X, Fan R, Zhang J, Guo D, et al
    Multimodal model for predicting exercise-induced pulmonary hypertension validated by invasive exercise hemodynamics: a prospective study.
    Respir Res. 2026 Jul 11. doi: 10.1186/s12931-026-03814.
    PubMed         Abstract available
    
    

    
    Rheumatol Int

33. ZHANG Y, Feng S, Zhang Y, Luo J, et al
    Development and internal validation of an interpretable machine learning model using routine laboratory data for systemic sclerosis-associated pulmonary arterial hypertension.
    Rheumatol Int. 2026;46:213.
    PubMed         Abstract available
    
    

    
    Zhongguo Dang Dai Er Ke Za Zhi

34. WANG W, Zhao T, Wang YM, Xie O, et al
    [Role of miR-146b-5p in hyperoxia-induced pulmonary vascular remodeling in neonatal rats: mechanisms based on the regulation of ferroptosis].
    Zhongguo Dang Dai Er Ke Za Zhi. 2026;28:885-892.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum